What happened
Shares of Innate Pharma(NASDAQ:IPHA), a clinical-stage biotechnology company, are rocketing higher in response to successful clinical-trial data for an experimental cancer drug called monalizumab. Investors surprised by the results pushed…

Click here to view the original article.